Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Longitudinal Population-based Observational Study of COVID-19 in the UK Population

Sponsor: Queen Mary University of London

NCT ID: NCT04330599

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Not specified by the sponsor
How long the study runs
Study runs about 75 months (dates as stated)
About the drug or intervention
Not specified by the sponsor
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
16 Years and over
Who
All
Number of participants
13,000
Started
2020-04-27
Last checked
2026-07

Plain English Summary

What is this study?

  • • Testing a new treatment for covid-19
  • • Clinical study - 13,000 participants
  • • COVIDENCE UK is a population-based observational longitudinal study that has the following objectives: 1

Who can take part?

  • • Ages 16 Years and over
  • • Diagnosed with covid-19

Where?

  • • London - Queen Mary University of London

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

COVIDENCE UK is a population-based observational longitudinal study that has the following objectives: 1. To determine risk factors for incident COVID-19 and for adverse outcomes of COVID-19 in the UK population 2. To characterise the natural history of COVID-19 in the UK population 3. To evaluate the impact of COVID-19 on the physical and mental health of the UK population 4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in COVIDENCE as comparison or control data for trial participants who have been randomised to receive one or more interventions.

COVID-19

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 16 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓UK resident
  • ✓Age ≥16 years
See the full criteria
Inclusion Criteria: * UK resident * Age ≥16 years Exclusion Criteria: none

Where Is This Study? (1 UK site)

Queen Mary University of London

London E1 2AB, United Kingdom

Recruiting
Site contact (verified)
Adrian R Martineau, MD PhD02078822551a.martineau@qmul.ac.uk

How to Get in Touch

Adrian Martineau, PhD

Sponsor contact

CONTACT

+442078822551 a.martineau@qmul.ac.uk

Hayley Holt, MSc

Sponsor contact

CONTACT

h.holt@qmul.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-07